UnitedHealth investors may seek roadmap on costs as Hemsley takes center stage
Hemsley returned to the role in May following the abrupt departure of then-CEO Andrew Witty, who stepped down amid rising operational and financial pressures.
The company's decision in May to withdraw its 2025 earnings forecast due to soaring medical costs and Medicare-related challenges sent its shares tumbling.
So far this year, UnitedHealth's stock has plunged more than 40%, dragging down the broader managed care sector with it.
"Investors will be looking for confidence that he (Hemsley) has got a handle on things and that he understands where things may have gone wrong and how they are going to correct it," said James Harlow, senior vice president at Novare Capital Management, which owns 46,333 shares of the healthcare company.
Hemsley, who ran the company from 2006 to 2017, has promised to rebuild trust, telling shareholders last month that regaining their confidence is a top priority.
The pressure is compounded by a federal investigation into UnitedHealth's Medicare billing practices. The company recently confirmed it was cooperating with both criminal and civil inquiries from the U.S. Department of Justice. These regulatory woes have only added to the uncertainty facing the insurer.
Wall Street analysts have lowered expectations throughout this month. Analysts expect a profit of $4.48 per share for the second quarter, according to data compiled by LSEG. That compares with expectations of $5.70 per share in May, when the company suspended its annual profit forecast.
UnitedHealth plans to establish "a prudent 2025 earnings outlook and offer initial perspectives for 2026," the company had said in June.
"Ultimately, on Tuesday, what we'd expect is more clarity on the way forward...we would expect a strategy, a roadmap laid out," said Sahil Bhatia, managing director of life sciences at Manning & Napier.
"I think one of the big issues over the last few months has been just the surprises...so we would expect more consistent execution going forward after laying out that roadmap," Bhatia said.
At least two investors said they anticipate UnitedHealth will reset its 2025 profit forecast in the range of $18 to $20 per share, far below the company's previous outlook of $26 to $26.50.
This might be conservative but is an appropriate start for Hemsley's first call, said Jeff Jonas, portfolio manager at Gabelli Funds.
UnitedHealth has previously built a reputation to guide conservatively and raise its outlook as the year progresses.
But this time, investors warn, withholding guidance altogether would be damaging. "If they continue to not give an EPS outlook for 2025, that will be damaging," Harlow added.
Apart from financial turbulence, the company has also faced reputational challenges. It has moved to ease prior authorization requirements after a public outcry following the killing of a UnitedHealth executive last December.
The Optum unit, once a growth driver for UnitedHealth, has also emerged as a key area of concern. Last quarter, the company flagged "unanticipated changes" in its Optum business that impacted planned 2025 reimbursements.
"Among all the overhangs, Optum Health remains the biggest concern," said Deutsche Bank analyst George Hill.
UnitedHealth has also grappled with the fallout from a major cyberattack last year that disrupted claims processing across its Change Healthcare unit.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
2 hours ago
- Reuters
S&P 500, Nasdaq hit new highs on corporate earnings, Fed meeting in focus
July 29 (Reuters) - The S&P 500 and the Nasdaq touched fresh record highs on Tuesday as investors assessed a spate of earnings and turned their focus to the U.S. Federal Reserve's much anticipated policy meeting. At 10:07 a.m. ET, the Dow (.DJI), opens new tab fell 0.08%, to 44,803.16, the S&P 500 (.SPX), opens new tab gained 7.45 points, or 0.12%, to 6,397.42, and the Nasdaq Composite (.IXIC), opens new tab gained 40.19 points, or 0.19%, to 21,218.78. The blue-chip index was currently about 200 points below its record peak. Key Dow components UnitedHealth (UNH.N), opens new tab and Boeing (BA.N), opens new tab reported mixed quarterly results on the day. Health insurer UnitedHealth fell 4.2% after a disappointing profit forecast, while Boeing lost 2.7% despite reporting a smaller second-quarter loss. UnitedHealth's stock has lost nearly half its value from the beginning of 2025. On the day, the healthcare index (.SPXHC), opens new tab lagged other sectors and was down 1.1%. Meanwhile, United Parcel Service (UPS.N), opens new tab became the latest victim of U.S. President Donald Trump's sweeping tariffs as the stock tumbled 8% after the company reported a lower-than-expected second-quarter profit. The S&P 500 and the Nasdaq were largely aided this week by a U.S.-EU trade deal that halved tariffs to 15% and boosted expectations of more agreements ahead of Trump's August 1 deadline. Trump has also floated a potential "world tariff" of 15% to 20% for non-negotiating countries. Key negotiations between the U.S. and China entered their second day in Stockholm as the two leading economies aim to iron out their trade conflict and possibly produce a 90-day extension to the tariff truce brokered in May. Meanwhile, India was preparing for higher U.S. tariffs — potentially as high as 25% — on some exports as it opts to hold the line on new trade concessions ahead of Washington's deadline, according to two Indian government sources. The International Monetary Fund was looking at the details of the trade agreements the United States has struck in recent days to assess their economic impact. Earnings from tech heavyweights Meta (META.O), opens new tab, Microsoft (MSFT.O), opens new tab, Amazon (AMZN.O), opens new tab and Apple (AAPL.O), opens new tab are scheduled later this week, which could test Wall Street's record run. Spotify (SPOT.N), opens new tab slumped 10% after the company forecast third-quarter profit below estimates. Meanwhile, consumer confidence in July increased more than expected to 97.2. U.S. job openings fell to 7.437 million in June, JOLTS data showed. However, recent data has shown resilience in the labor market despite initial signs of inflation from tariffs. "It looks like companies are tightening up their hiring. The proportion that it dropped wasn't large, but it's not in the right direction," said Kim Forrest, chief investment officer at Bokeh Capital Partners. The U.S. central bank is set to begin its two-day policy meeting later in the day. While the Fed is expected to leave rates unchanged on Wednesday, traders will closely analyze policymakers' remarks to gauge the timing of future moves. According to the CME FedWatch tool, markets are pricing in about a 63.6% chance of a rate cut in September. Among other earnings-related moves, Cadence Design (CDNS.O), opens new tab rose 10% after the chip design software provider raised its annual sales and profit forecast. Advancing issues outnumbered decliners by a 1.5-to-1 ratio on the NYSE, while declining issues outnumbered advancers by a 1.17-to-1 ratio on the Nasdaq. The S&P 500 posted 29 new 52-week highs and nine new lows, while the Nasdaq Composite recorded 53 new highs and 34 new lows.
Reuters
4 hours ago
- Reuters
Wall St headed for higher open with focus on earnings, Fed meeting
July 29 (Reuters) - Wall Street's main indexes were poised for a higher open on Tuesday as investors assessed a plethora of earnings releases from top U.S. companies and looked ahead to the Federal Reserve's upcoming two-day monetary policy meeting. At 8:20 a.m. ET, S&P 500 E-minis were up 14.5 points, or 0.23%, Nasdaq 100 E-minis were up 105.75 points, or 0.45%, and Dow E-minis were up 69 points, or 0.15%. A higher open for the Dow could help it reach a new record high, with the index currently about 200 points below its peak. Its key components, UnitedHealth (UNH.N), opens new tab and Boeing (BA.N), opens new tab, reported mixed quarterly results. Health insurer UnitedHealth fell about 1% in premarket trading following a disappointing profit forecast, while Boeing gained 2% thanks to a smaller second-quarter loss. Meanwhile, United Parcel Service (UPS.N), opens new tab became the latest victim of U.S. President Donald Trump's sweeping tariffs, with the stock falling 3% after the company reported a lower-than-expected second-quarter profit. On Monday, the S&P 500 and the Nasdaq scored fresh record closes in volatile trading, aided by a U.S.-EU trade deal that halved tariffs to 15% and boosted expectations of more agreements ahead of Trump's looming August 1 deadline. The President has also floated a potential "world tariff" of 15-20% for non-negotiating countries. Key negotiations between the U.S. and China entered their second day in Stockholm, as the two leading economies aim to iron out their trade conflict and possibly produce a 90-day extension to the tariff truce brokered in May. Earnings from tech heavyweights Meta (META.O), opens new tab, Microsoft (MSFT.O), opens new tab, Amazon (AMZN.O), opens new tab and Apple (AAPL.O), opens new tab are scheduled for later this week, which could test Wall Street's record run. "The easiest gains (on Wall St) have now happened, and any further rise is likely to happen much more slowly," said Thomas Mathews, head of Markets at Capital Economics. The continuation of the rally may depend heavily on Big Tech profits "continuing to paint a positive picture," he said. Spotify (SPOT.N), opens new tab tumbled 5.4% after the company forecast third-quarter profit below estimates. The U.S. central bank is set to begin its two-day policy meeting later in the day. While the Fed is expected to leave rates unchanged on Wednesday, traders will closely analyze policymakers' remarks to gauge the timing of future moves. According to the CME FedWatch tool, markets are pricing in about a 63% chance of a rate cut in September. The meeting comes amid the White House's campaign on the central bank to lower borrowing costs, including Trump's persistent criticism of Fed Chair Jerome Powell and occasional suggestions to remove him from his position. At 10:00 a.m. ET, investors will analyze the U.S. Job Openings and Labor Turnover Survey (JOLTS) to test the strength of the labor market, which has shown resilience in recent weeks despite signs of inflation from tariffs. The JOLTS report will set the stage for the ADP private payrolls data on Wednesday, weekly jobless claims on Thursday, and non-farm payrolls on Friday. The consumer confidence report is also due for the day. Among other earnings-related moves, Cadence Design (CDNS.O), opens new tab rose 8.3% in premarket trading after the chip design software provider raised its annual sales and profit forecast.
Reuters
4 hours ago
- Reuters
UnitedHealth signals prolonged pain as restored profit forecast underwhelms
July 29 (Reuters) - UnitedHealth (UNH.N), opens new tab on Tuesday restored its full-year profit forecast that it suspended months ago, with a new outlook that highlighted the challenges the U.S. insurer faced, including rising medical costs. The company projected full-year earnings per share of at least $16, well short of analysts' lowered estimates, while second-quarter profit fell short of expectations. Its shares were trading down about 5% in premarket trading, set to add to the more than 40% slump this year. UnitedHealth and other insurers have been hit hard this year by elevated medical costs. The company's underperformance led to the abrupt departure of CEO Andrew Witty in May. Stephen Hemsley, who returned as CEO, is under pressure to regain investor trust amid the company's financial struggles and reputational damage. At least three analysts said investors, who were hoping for annual profit per share to be between $18 and $20, will be looking for management comments on the longer-term earnings power of the business. The commentary on the extended earnings call will be critical in framing how conservative UnitedHealth's forecast is and the potential upside entering 2026, when the company anticipates a return to growth, said J.P. Morgan analyst Lisa Gill. The company's new adjusted profit forecast is almost half of the range of $29.50 and $30.00 per share it had initially set in December. It posted an adjusted profit of $27.66 per share in 2024. UnitedHealth said its new forecast reflects expectations for higher realized and anticipated care trends. The company suspended its 2025 profit forecast in May, a historic first for the insurer, citing higher-than-anticipated medical expenditures, which have also rattled its peers. UnitedHealth said medical cost trends in its Medicare Advantage plans for older adults are expected to run at about 7.5% in 2025, exceeding its pricing expectations of just over 5%. The company anticipates these trends to continue to accelerate to nearly 10% next year. The company's quarterly medical loss ratio - the percentage of premiums spent on medical care - stood at 89.4%, higher than estimates of 88.58%. The company's Optum unit, once a growth driver, has also emerged as a key area of concern. Optum Health's quarterly revenue fell 7% to $25.2 billion, hurt by legacy customer contract revisions. "That's an area that just all of a sudden seems like it sort of fell apart. I think their explanations have not been totally adequate," said James Harlow, senior vice president at Novare Capital Management. UnitedHealth's adjusted second-quarter profit of $4.08 per share missed analysts' average estimate of $4.48.
